Applying for CDSCO license for your drug? Make Sure your formulation does not have similar brand name Farhat Nasim9 Nov 2019 4:52 PM ISTNew Delhi: In a bid to curb the irrational practice of using similar names for different drugs that results in utter confusion, the Union Health...
CDSCO Committee to draft new guidelines for effective recall of substandard drugs Farhat Nasim7 Oct 2019 5:29 PM ISTNew Delhi: To examine the issues regarding effective recall system of drugs found Not of Standard Quality (NSQ) and to review the recall guidelines...
Cipla launches skin treatment Daptomycin Injection in US Medical Dialogues Bureau27 Sept 2019 1:53 PM ISTDrug firm Cipla on Wednesday said it has launched Daptomycin Injection, used for treating complicated skin infections, in the US market. Daptomycin...
Strides Pharma suspends sale of Ranitidine tab in US Medical Dialogues Bureau27 Sept 2019 9:56 AM ISTNew Delhi: Strides Pharma Science on Friday suspended the sale of Ranitidine tablets after it received an information request from the US health...
GSK Belantamab Mafodotin shows to help blood cancer patients Medical Dialogues Bureau26 Aug 2019 9:15 AM ISTTwo doses of Belantamab Mafodotin helped subdue the disease in adults who had received three prior treatments for multiple myeloma, a cancer of the...
Zydus Cadila wins USFDA nod for Minocycline Hydrochloride ER tablets to treat acne Medical Dialogues Bureau3 Aug 2019 9:45 AM ISTMinocycline hydrochloride extended-release tablets are indicated to treat only inflammatory lesions of non-modular moderate to severe acne vulgaris in...
Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor Medical Dialogues Bureau9 July 2019 12:49 PM ISTMumbai: Sun Pharma Advanced Research Company (SPARC) on Monday said the US health regulator has given orphan drug designation to its novel kinase...
Drug marketers as liable as Drug Manufacturers for quality, efficacy, regulatory compliance: Health Ministry Issues Draft Farhat Nasim28 Jun 2019 4:44 PM ISTNew Delhi: Through a recent draft Gazette notification, the Ministry of Health and Family Welfare has informed that not just drugmakers but drug...
Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH Medical Dialogues Bureau19 Jun 2019 12:01 PM ISTAHMEDABAD: Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrolment of 104 patients with...
GSK pharma head flags need for speed in high-pressure drug market Medical Dialogues Bureau18 Jun 2019 2:06 PM ISTLONDON: Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at...
Delhi High Court stays Centres circular banning manufacture, sale of e-cigarettes Medical Dialogues Bureau20 May 2019 9:15 AM ISTThe Centre contended that it is yet to be determined whether e-cigarettes are safer.New Delhi: The Delhi High Court has stayed the Centre's circular...
Cipla gets no USFDA observations for Indore facility Farhat Nasim18 May 2019 9:45 AM ISTThe US health regulator conducted a post-approval inspection at Cipla Ltd's Indore facility from 13th May to 17th May 2019. New Delhi: Drug firm Cipla...
